BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30361876)

  • 1. Prevalence of human pathogens of the clade Nakaseomyces in a culture collection-the first report on Candida bracarensis in Poland.
    Małek M; Mrowiec P; Klesiewicz K; Skiba-Kurek I; Szczepański A; Białecka J; Żak I; Bogusz B; Kędzierska J; Budak A; Karczewska E
    Folia Microbiol (Praha); 2019 May; 64(3):307-312. PubMed ID: 30361876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait.
    Asadzadeh M; Alanazi AF; Ahmad S; Al-Sweih N; Khan Z
    PLoS One; 2019; 14(10):e0223920. PubMed ID: 31618264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina.
    Morales-López SE; Taverna CG; Bosco-Borgeat ME; Maldonado I; Vivot W; Szusz W; Garcia-Effron G; Córdoba SB
    Mycopathologia; 2016 Dec; 181(11-12):871-878. PubMed ID: 27681573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of a multiplex PCR for the rapid identification of Candida glabrata species complex in Mexican clinical isolates.
    Reyes-Montes MDR; Acosta-Altamirano G; Duarte-Escalante E; Salazar EG; Martínez-Herrera E; Arenas R; González G; Frías-De-León MG
    Rev Inst Med Trop Sao Paulo; 2019 Aug; 61():e37. PubMed ID: 31411267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
    Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
    J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.
    Tay ST; Lotfalikhani A; Sabet NS; Ponnampalavanar S; Sulaiman S; Na SL; Ng KP
    Mycopathologia; 2014 Oct; 178(3-4):307-14. PubMed ID: 25022264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.
    Bishop JA; Chase N; Magill SS; Kurtzman CP; Fiandaca MJ; Merz WG
    J Clin Microbiol; 2008 Feb; 46(2):443-6. PubMed ID: 18077641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Candida nivariensis and Candida bracarensis in vulvovaginal Candidiasis.
    Li J; Shan Y; Fan S; Liu X
    Mycopathologia; 2014 Oct; 178(3-4):279-83. PubMed ID: 25118875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Candida glabrata complex species: use of Vitek MS
    Hou X; Xiao M; Chen SC; Kong F; Wang H; Fan X; Zhao YP; Xu YC
    Future Microbiol; 2018 May; 13():645-657. PubMed ID: 29745727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Antifungal Susceptibility Profiles of
    Hou X; Xiao M; Chen SC; Wang H; Yu SY; Fan X; Kong F; Xu YC
    Front Microbiol; 2017; 8():5. PubMed ID: 28154553
    [No Abstract]   [Full Text] [Related]  

  • 12. Candida nivariensis in comparison to different phenotypes of Candida glabrata.
    Swoboda-Kopeć E; Sikora M; Golas M; Piskorska K; Gozdowski D; Netsvyetayeva I
    Mycoses; 2014 Dec; 57(12):747-53. PubMed ID: 25267284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of nine cryptic species of Candida albicans, C. glabrata, and C. parapsilosis complexes using one-step multiplex PCR.
    Arastehfar A; Fang W; Pan W; Liao W; Yan L; Boekhout T
    BMC Infect Dis; 2018 Sep; 18(1):480. PubMed ID: 30253748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Old and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance.
    Angoulvant A; Guitard J; Hennequin C
    FEMS Yeast Res; 2016 Mar; 16(2):fov114. PubMed ID: 26691882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.
    Lockhart SR; Messer SA; Gherna M; Bishop JA; Merz WG; Pfaller MA; Diekema DJ
    J Clin Microbiol; 2009 Apr; 47(4):1216-7. PubMed ID: 19193845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Isolation of Candida nivariensis, an Emerging Fungal Pathogen, in Kuwait.
    Alobaid K; Asadzadeh M; Bafna R; Ahmad S
    Med Princ Pract; 2021; 30(1):80-84. PubMed ID: 32927454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia.
    Cuenca-Estrella M; Gomez-Lopez A; Isla G; Rodriguez D; Almirante B; Pahissa A; Rodriguez-Tudela JL;
    Med Mycol; 2011 Jul; 49(5):525-9. PubMed ID: 21198347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex PCR designed to differentiate species within the Candida glabrata complex.
    Dudiuk C; Morales-López SE; Podesta V; Macedo D; Leonardelli F; Vitale RG; Tosello ME; Cabeza MS; Biasoli M; Gamarra S; Garcia-Effron G
    Rev Iberoam Micol; 2017; 34(1):43-45. PubMed ID: 27810263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.
    Morales-López S; Dudiuk C; Vivot W; Szusz W; Córdoba SB; Garcia-Effron G
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNA.
    Mirhendi H; Bruun B; Schønheyder HC; Christensen JJ; Fuursted K; Gahrn-Hansen B; Johansen HK; Nielsen L; Knudsen JD; Arendrup MC
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1409-16. PubMed ID: 21607825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.